Leadership Team
Neopharma Technologies Ltd, is an Australian public company, participating in the multi-billion-dollar global Point-of-Care (POC) health testing market with NEOVAULT®.
NEOVAULT® is the first device-agnostic point-of-care solution that integrates drug and alcohol testing with cognitive & psychomotor impairment screening, delivering a complete picture of workforce Fit-for Duty. This is complemented by a comprehensive range of advanced rapid test kits.
With innovation at its core, Neopharma is redefining healthcare diagnostics, transforming how workplace safety, healthcare, and productivity intersect.
Vision Statement
Neopharma Technologies aims to be the recognized global leader for innovative digital health-care technologies. To promote a healthier and safer world.
Mission Statement
Neopharma’s mission is to have NEOVAULT® become the world's default digital layer for drug, alcohol and impairment testing globally providing end-to-end workforce Fit-for-Duty compliance
Leadership Team
Marcus L'Estrange
Executive Chairman
Marcus is an engineer who has over 30 years’ experience working across IT, Medtech, Environmental, Mining, and Oil & Gas industries. He has been involved with the start-up of successful companies within these sectors. Marcus successfully commercialized SurvOpt offshore exploration software globally during his tenure at Engenius Software, progressing the company from Australian start-up to a key global industry participant. Marcus has held positions of Chairman, Managing Director, Director and Company Secretary of Australian Public and Private companies and has successfully listed and reverse-listed companies on the ASX. In his current role of Executive Chairman with Neopharma Technologies, Marcus sets and manages the company’s global growth strategy, operations, funding and compliance.
Enquire Now
